FDA Investigator: Ann M. Montemurro
- Ann M. Montemurro first started conducting FDA inspections in 2000, with the last inspection in 2010. Over that time, Ann M. Montemurro has conducted 69 inspections at 51 companies across 52 sites.
Get Ann Montemurro's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Sanofi Pasteur, Swiftwater | April 2006
Available Now - $199
Ann M. Montemurro
Biologic Form 483
FDA 483 Ortho-Clinical Diagnostics, Inc., Raritan | 2010
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 MedImmune, LLC, Philadelphia | 2009
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 MedImmune, LLC, Philadelphia | 2009
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Lonza Walkersville, Inc., Walkersville | 2008
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 ID Biomedical Corp., a subsidary of GSK Biologicals, St. Foy | 2008
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Ortho-Clinical Diagnostics, Inc., Raritan | 2008
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Merck Sharpe & Dohme Corp, West Point | 2008
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Roche Diagnostics GmbH, Penzberg | 2007
Out-of-stock
Ann M. Montemurro
Human Drug Form 483
FDA 483 Millipore (U.K.) Ltd., Livingston | 2007
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Hoffmann La Roche Inc, Nutley | 2007
Out-of-stock
Ann M. Montemurro
Human Drug Form 483
FDA 483 MedImmune, LLC, Philadelphia | 2007
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Enzon Pharmaceuticals, Inc, South Plainfield | 2007
Out-of-stock
Ann M. Montemurro
Human Drug Form 483
FDA 483 Roche Molecular Systems, Inc., Belleville | 2007
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Roche Molecular Systems, Inc., Branchburg | 2007
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Janssen Biotech, Inc., Malvern | 2006
Out-of-stock
Ann M. Montemurro
Human Drug Form 483
FDA 483 Immucor, Inc., Norcross | 2006
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Octapharma Pharmazeutika Produktionsges, m.b.h., Vienna | 2006
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Patheon Italia S.p.A., Monza | 2006
Out-of-stock
Ann M. Montemurro
Human Drug Form 483
FDA 483 ORTHO-CLINICAL DIAGNOSTICS, Raritan | 2005
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Laureate Biopharmaceuticals Services, Inc., Princeton | 2005
Out-of-stock
Ann M. Montemurro
Human Drug Form 483
FDA 483 Palatin Technologies, Inc., Cranbury | 2005
Out-of-stock
Ann M. Montemurro
Human Drug Form 483
FDA 483 Lampire Biological Labs, Pipersville | 2005
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 MedImmune, LLC, Philadelphia | 2005
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Medimmune U.K., Liverpool | 2005
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 MedImmune U.K. Limited, Liverpool | 2005
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 GlaxoSmithKline LLC, Conshohocken | 2005
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Hoffmann La Roche Inc, Nutley | 2005
Out-of-stock
Ann M. Montemurro
Human Drug Form 483
FDA 483 ID Biomedical Corp., a subsidary of GSK Biologicals, St. Foy | 2004
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Advanced BioScience Laboratories Inc, Kensington | 2004
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Amgen, Inc., Boulder | 2004
Out-of-stock
Ann M. Montemurro
Human Drug Form 483
FDA 483 Halo Pharmaceutical, Inc., Whippany | 2004
Out-of-stock
Ann M. Montemurro
Human Drug Form 483
FDA 483 Merck Sharpe & Dohme Corp, West Point | 2004
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Janssen Biotech, Inc., Malvern | 2004
Out-of-stock
Ann M. Montemurro
Human Drug Form 483
FDA 483 Laureate Biopharmaceuticals Services, Inc., Princeton | 2003
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Novartis Pharma AG, Basel | 2003
Out-of-stock
Ann M. Montemurro
Biologic Form 483
FDA 483 Crucell Switzerland AG, Berne | 2003
Out-of-stock
Ann M. Montemurro
Biologic Form 483
Co-Investigators (32)
- Paula A. Trost, FDA Investigator
- Joan A. Loreng, FDA Investigator
- Susan S. Yu, FDA Investigator
- Edward Patten, FDA Investigator
- Martha T. Olone, FDA Investigator
- Jacqueline M. Diaz Albert, FDA Investigator
- Diaz Albert, Jacqueline M, FDA Investigator
- Prabhu P. Raju, FDA Investigator
- Kristy A. Zielny, FDA Investigator
- Kristina J. Donohue, FDA Investigator
- Mihaly S. Ligmond, FDA Investigator
- Sid B. Priesmeyer, FDA Investigator
- Helen B. Ricalde, FDA Investigator
- Cynthia Jim, FDA Investigator
- Julie D. Bringger, FDA Investigator
- Myra K. Casey, FDA Investigator
- Ralph A. Erickson, FDA Investigator
- Ann L. Demarco, FDA Investigator
- Mariza M. Jafary, FDA Investigator
- Nancy L. Neiger, FDA Investigator
- Sarah M. Forney, FDA Investigator
- Ana S. Cabrera, FDA Investigator
- Richard W. Thornton, FDA Investigator
- Omotunde O. Osunsanmi, FDA Investigator
- Jeffrey M. Watson, FDA Investigator
- Eliezer Ramos, FDA Investigator
- David J. Hafner, FDA Investigator
- James C. Maclaughlin, FDA Investigator
- Shelley L. Waring, FDA Investigator
- James R. Evans, FDA Investigator
- Marsha W. Major, FDA Investigator
- Debra L. Pagano, FDA Investigator